Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Seagen Inc SGEN

Healthcare Biotechnology
Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers; TUKYSA, or tucatinib, for the treatment of certain metastatic... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SGEN)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:SGEN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SGEN)

RE:SGEN

https://ceo.ca/api/sedi?symbol=AII&amount=&transaction=buy-sell&insider=
whoisyourpapa - May 25, 2023

SGEN

https://ceo.ca/api/sedi?symbol=AII&amount=&transaction=buy-sell&insider=
whoisyourpapa - May 25, 2023

Next SGEN

$APC Similar model. Took one great invention and licensed it out to a whack ton of partners. Massive company grew from this.  ...
Goldnboy1 - February 5, 2022

Why Seattle Genetics is holding strong

 This biotechnology company is primarily focused on developing and commercializing therapies targeted for the treatment of cancer...
DerdreeLove2019 - June 24, 2020

ixs - super antibody tech

In the same space as SGEN but miles cheaper - might be worth a look to some big pharma.
mouserman - May 8, 2008

RE: Has anyone heard anything about

I have just heard about this one from stockgumshoe.com - a site dedicated to sleuthing teaser ads. This one comes in a teaser ad for the...
mikeyr47 - March 5, 2008
View more Bullboard ››

Enerev5 Metals Inc

Enerev5 Metals Inc

Enerev5 Metals Inc. is a Canadian resource company. The Company is focused on the exploration and development potential ...
View More »